UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5601
AlTi Global
ALTI
$269M
| $1.11M | ﹤0.01% |
306,625
+137,327
| +81% | +$475K |
2022 Q1
17 quarters
|
|
5602
PUT
Daqo New Energy
DQ
$856M
| $1.1M | ﹤0.01% |
82,500
+80,000
| +3,200% | +$1.45M |
2026 Q1
1 quarter
|
|
5603
Claritev Corp
CTEV
$385M
| $1.1M | ﹤0.01% |
32,340
+3,568
| +12% | +$87.4K |
2022 Q3
15 quarters
|
|
5604
Intrepid Potash
IPI
$440M
| $1.1M | ﹤0.01% |
33,646
+14,403
| +75% | +$548K |
2014 Q4
46 quarters
|
|
5605
CTS Corp
CTS
$1.65B
| $1.1M | ﹤0.01% |
16,882
-53,708
| -76% | -$3.22M |
2014 Q4
46 quarters
|
|
5606
HighPeak Energy
HPK
$903M
| $1.1M | ﹤0.01% |
157,318
+140,640
| +843% | +$970K |
2021 Q4
18 quarters
|
|
5607
GoldMining Inc
GLDG
$168M
| $1.1M | ﹤0.01% |
1,209,801
+1,004,524
| +489% | +$1.12M |
2023 Q1
13 quarters
|
|
5608
AngioDynamics
ANGO
$493M
| $1.1M | ﹤0.01% |
84,187
-307,098
| -78% | -$3.5M |
2014 Q4
46 quarters
|
|
5609
Petco
WOOF
$848M
| $1.09M | ﹤0.01% |
402,496
-101,513
| -20% | -$282K |
2021 Q1
21 quarters
|
|
5610
Danaos Corp
DAC
$2.7B
| $1.09M | ﹤0.01% |
8,946
-31,919
| -78% | -$3.99M |
2020 Q4
22 quarters
|
|
5611
Invesco S&P SmallCap Health Care ETF
PSCH
$180M
| $1.09M | ﹤0.01% |
20,891
-1,386
| -6% | -$63.1K |
2018 Q2
32 quarters
|
|
5612
Relmada Therapeutics
RLMD
$416M
| $1.09M | ﹤0.01% |
158,033
+31,361
| +25% | +$219K |
2019 Q4
26 quarters
|
|
5613
Capital Bancorp
CBNK
$692M
| $1.09M | ﹤0.01% |
31,079
+1,293
| +4% | +$41.4K |
2022 Q4
14 quarters
|
|
5614
BlackRock Enhanced International Dividend Trust
BGY
$488M
| $1.09M | ﹤0.01% |
190,084
-123,657
| -39% | -$706K |
2014 Q4
46 quarters
|
|
5615
Bright Minds Biosciences
DRUG
$227M
| $1.09M | ﹤0.01% |
15,536
+2,256
| +17% | +$177K |
2024 Q3
7 quarters
|
|
5616
Southern California Bancorp
BCAL
$696M
| $1.09M | ﹤0.01% |
52,319
-5,342
| -9% | -$102K |
2023 Q2
12 quarters
|
|
5617
PLDT
PHI
$3.95B
| $1.09M | ﹤0.01% |
62,087
+60,261
| +3,300% | +$1.17M |
2014 Q4
46 quarters
|
|
5618
PUT
UiPath
PATH
$6.78B
| $1.09M | ﹤0.01% |
100,000
| – | – |
2024 Q4
6 quarters
|
|
5619
Blend Labs
BLND
$233M
| $1.09M | ﹤0.01% |
635,392
-91,036
| -13% | -$145K |
2024 Q1
9 quarters
|
|
5620
BRC Group Holdings
RILY
$147M
| $1.09M | ﹤0.01% |
135,137
+117,263
| +656% | +$997K |
2017 Q3
35 quarters
|
|
5621
PUT
Trade Desk
TTD
$6.11B
| $1.08M | ﹤0.01% |
60,000
+59,700
| +19,900% | +$1.27M |
2023 Q3
11 quarters
|
|
|
DPC
5622
DPC Holdings PLC
DPC
$4.3B
| $1.08M | ﹤0.01% |
+22,092
| New | +$1.08M |
2026 Q2
0 quarters
|
|
5623
PUT
KKR & Co
KKR
$86.6B
| $1.08M | ﹤0.01% |
11,800
-72,600
| -86% | -$7.04M |
2024 Q4
6 quarters
|
|
5624
Blackstone Long-Short Credit Income Fund
BGX
$136M
| $1.08M | ﹤0.01% |
99,528
-1,130
| -1% | -$12.3K |
2014 Q4
46 quarters
|
|
5625
Digi Power X Inc
DGXX
$211M
| $1.08M | ﹤0.01% |
198,316
+158,803
| +402% | +$866K |
2025 Q3
3 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.